Valuation: IRADIMED CORPORATION

Market Cap 1.06B 914M 863M 783M 1.47B 101B 1.48B 10.31B 3.97B 51.31B 3.96B 3.88B 163B P/E 2026 *
43x
P/E 2027 * 37.2x
Enterprise Value 1.06B 914M 863M 783M 1.47B 101B 1.48B 10.31B 3.97B 51.31B 3.96B 3.88B 163B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 10.4x
Free-Float
64.83%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week-1.10%
Current month-4.46%
1 month-5.08%
3 months-11.83%
6 months-17.21%
Current year-15.16%
1 week 81.4
Extreme 81.405
85.11
1 month 81.4
Extreme 81.405
89.13
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
3/9/26 Sell

Director

-1,419 0.0111%
4/6/26 Sell

Director

-3,000 0.0235%
1/6/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-1.10%+15.80%+80.63% 1.06B
-0.74%-4.56%-32.26%-1.68% 12.46B
-0.40%-6.12%+10.75%+12.74% 4.12B
-1.25%-8.65%-47.41%-59.49% 1.2B
-0.10%-5.02%-44.24%-43.91% 1.06B
+1.47%-5.72%-40.49% - 967M
+1.31%-7.78% - - 965M
+3.07%-3.42%+31.77%+102.94% 503M
-1.36%+8.68%+58.01% - 326M
-5.31%-4.08%-69.32%+322.60% 246M
Average -0.38%-3.32%-13.05%+59.12% 2.29B
Weighted average by Cap. -0.46%-4.38%-21.26%+6.29%

Financials

2026 *2027 *
Net sales 91.2M 79.02M 74.58M 67.66M 127M 8.74B 128M 891M 343M 4.43B 343M 335M 14.1B 101M 87.52M 82.59M 74.93M 141M 9.68B 142M 986M 380M 4.91B 379M 371M 15.61B
Net income 24.65M 21.36M 20.16M 18.29M 34.3M 2.36B 34.55M 241M 92.76M 1.2B 92.58M 90.54M 3.81B 28.45M 24.65M 23.26M 21.11M 39.59M 2.73B 39.88M 278M 107M 1.38B 107M 104M 4.4B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
15/09/26 USD 82.53 +0.38% 90,160
11/09/26 USD 82.22 +0.43% 285,625
10/09/26 USD 81.87 -2.02% 120,200
09/09/26 USD 83.56 -1.00% 74,731
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
82.53USD
Average target price
118.00USD
Spread / Average Target
+42.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!